🟢 MEDPAL AI is trading 6.1% up with no clear catalyst identified

MEDPAL AI is trading 6.1% higher at £4.35, with no clear catalyst identified.

• No new company-specific announcement dated September 1, 2026 was identified.
• Recent updates include the August 11, 2026 UK authorisation of Eli Lilly’s oral GLP-1 pill, which predates this move.
• Broader markets were broadly flat, offering no clear global catalyst for the increase.